AIMS/HYPOTHESIS: The aim of this study was to develop and validate a score for detecting the glycaemic categories of impaired glucose regulation (IGR) and type 2 diabetes using the WHO 2011 diagnostic criteria. METHODS: We used data from 6,390 individuals aged 40-75 years from a multiethnic population based screening study. We developed a logistic regression model for predicting IGR and type 2 diabetes (diagnosed using OGTT or HbA(1c) ≥ 6.5% [48 mmol/mol]) from data which are routinely stored in primary care. We developed the score by summing the β coefficients. We externally validated the score using data from 3,225 participants aged 40-75 years screened as part of another study. RESULTS: The score includes age, ethnicity, sex, family history of diabetes, antihypertensive therapy and BMI. Fifty per cent of a population would need to be invited for testing to detect type 2 diabetes mellitus on OGTT with 80% sensitivity; this is slightly raised to 54% that need to be invited if using HbA(1c). Inviting the top 10% for testing, 9% of these would have type 2 diabetes mellitus using an OGTT (positive predictive value [PPV] 8.9% [95% CI 5.8%,12.8%]), 26% would have IGR (PPV 25.9% [95% CI 20.9%, 31.4%]). Using HbA(1c) increases the PPV to 19% for type 2 diabetes mellitus (PPV 18.6% [95% CI 14.2%, 23.7%]) and 28% for an HbA(1c) between 6.0% and 6.4% (PPV 28.3% [95% CI 23.1%, 34.0%]). CONCLUSIONS: The score can be used to reliably identify those with undiagnosed IGR and type 2 diabetes in multiethnic populations. This is the first score developed taking into account HbA(1c) in the diagnosis of type 2 diabetes.
AIMS/HYPOTHESIS: The aim of this study was to develop and validate a score for detecting the glycaemic categories of impaired glucose regulation (IGR) and type 2 diabetes using the WHO 2011 diagnostic criteria. METHODS: We used data from 6,390 individuals aged 40-75 years from a multiethnic population based screening study. We developed a logistic regression model for predicting IGR and type 2 diabetes (diagnosed using OGTT or HbA(1c) ≥ 6.5% [48 mmol/mol]) from data which are routinely stored in primary care. We developed the score by summing the β coefficients. We externally validated the score using data from 3,225 participants aged 40-75 years screened as part of another study. RESULTS: The score includes age, ethnicity, sex, family history of diabetes, antihypertensive therapy and BMI. Fifty per cent of a population would need to be invited for testing to detect type 2 diabetes mellitus on OGTT with 80% sensitivity; this is slightly raised to 54% that need to be invited if using HbA(1c). Inviting the top 10% for testing, 9% of these would have type 2 diabetes mellitus using an OGTT (positive predictive value [PPV] 8.9% [95% CI 5.8%,12.8%]), 26% would have IGR (PPV 25.9% [95% CI 20.9%, 31.4%]). Using HbA(1c) increases the PPV to 19% for type 2 diabetes mellitus (PPV 18.6% [95% CI 14.2%, 23.7%]) and 28% for an HbA(1c) between 6.0% and 6.4% (PPV 28.3% [95% CI 23.1%, 34.0%]). CONCLUSIONS: The score can be used to reliably identify those with undiagnosed IGR and type 2 diabetes in multiethnic populations. This is the first score developed taking into account HbA(1c) in the diagnosis of type 2 diabetes.
Authors: D R Webb; L J Gray; K Khunti; B Srinivasan; N Taub; S Campbell; J Barnett; A Farooqi; J B Echouffo-Tcheugui; S J Griffin; N J Wareham; M J Davies Journal: Diabetologia Date: 2011-06-03 Impact factor: 10.122
Authors: L J Gray; N A Taub; K Khunti; E Gardiner; S Hiles; D R Webb; B T Srinivasan; M J Davies Journal: Diabet Med Date: 2010-08 Impact factor: 4.359
Authors: Simon J Griffin; Knut Borch-Johnsen; Melanie J Davies; Kamlesh Khunti; Guy E H M Rutten; Annelli Sandbæk; Stephen J Sharp; Rebecca K Simmons; Maureen van den Donk; Nicholas J Wareham; Torsten Lauritzen Journal: Lancet Date: 2011-06-24 Impact factor: 79.321
Authors: J Henson; T Yates; S J H Biddle; C L Edwardson; K Khunti; E G Wilmot; L J Gray; T Gorely; M A Nimmo; M J Davies Journal: Diabetologia Date: 2013-03-01 Impact factor: 10.122
Authors: Matthew McCarthy; Charlotte L Edwardson; Melanie J Davies; Joseph Henson; Laura Gray; Kamlesh Khunti; Thomas Yates Journal: Med Sci Sports Exerc Date: 2017-06 Impact factor: 5.411
Authors: Thomas Yates; Joe Henson; Charlotte Edwardson; Danielle H Bodicoat; Melanie J Davies; Kamlesh Khunti Journal: BMJ Open Date: 2015-07-23 Impact factor: 2.692
Authors: Tom Yates; Simon Griffin; Danielle H Bodicoat; Gwen Brierly; Helen Dallosso; Melanie J Davies; Helen Eborall; Charlotte Edwardson; Mike Gillett; Laura Gray; Wendy Hardeman; Sian Hill; Katie Morton; Stephen Sutton; Jacqui Troughton; Kamlesh Khunti Journal: Trials Date: 2015-07-02 Impact factor: 2.279
Authors: Thomas Yates; Melanie J Davies; Joseph Henson; Charlotte Edwardson; David Webb; Danielle H Bodicoat; M'Balu Webb; Philip Howard; Jackie A Cooper; Steve E Humphries; Kamlesh Khunti; Philippa Talmud Journal: PLoS One Date: 2015-05-14 Impact factor: 3.240
Authors: L J Gray; K Khunti; C Edwardson; S Goldby; J Henson; D H Morris; D Sheppard; D Webb; S Williams; T Yates; M J Davies Journal: Diabetologia Date: 2012-09-22 Impact factor: 10.122
Authors: Gregory J H Biddle; Joseph Henson; Stuart J H Biddle; Melanie J Davies; Kamlesh Khunti; Alex V Rowlands; Stephen Sutton; Thomas Yates; Charlotte L Edwardson Journal: Int J Environ Res Public Health Date: 2021-06-08 Impact factor: 3.390